POMGNT1: A Potential Drug Target Or Biomarker (G55624)

Target Name: POMGNT1

NCBI ID: G55624

POMGNT1

POMGNT1: A Potential Drug Target Or Biomarker

POMGNT1 (gnT-I.2) is a protein that is expressed in the nervous system and has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is also expressed in the heart and has been linked to heart disease, suggesting that it may be a potential drug target or biomarker.

POMGNT1 function and localization

POMGNT1 is a transmembrane protein that is involved in the formation of the endosomal system, which is responsible for the delivery of proteins to various cell types in the body. It is composed of a cytoplasmic tail that is involved in the formation of the endosomal vesicle and a transmembrane domain that is involved in the interaction with various cellular and intracellular structures.

POMGNT1 is primarily localized to the endosomal system, where it is involved in the formation of the endosomal vesicle, which is a structure that is formed by the fusion of the cytoplasmic tail of the protein with the transmembrane domain. The endosomal vesicle then moves to the endosomal membrane and forms a vesicle that is filled with various proteins, including POMGNT1.

POMGNT1 is also expressed in various other cell types in the body, including the heart. It has been shown to play a role in the development and progression of various cardiovascular diseases, including heart failure, hypertension, and myocardial infarction.

POMGNT1 as a drug target

POMGNT1 has been shown to be involved in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is thought to contribute to the pathogenesis of these disorders by participating in the formation of the endosomal system and the delivery of harmful proteins to the brain.

In addition, POMGNT1 has also been shown to be involved in the development of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease. It is thought to contribute to the pathogenesis of these disorders by participating in the formation of the endosomal system and the delivery of harmful proteins to the brain.

POMGNT1 has also been shown to be involved in the development and progression of various autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. It is thought to contribute to the pathogenesis of these disorders by participating in the formation of the endosomal system and the delivery of harmful proteins to the central nervous system.

POMGNT1 as a biomarker

POMGNT1 has also been shown to be a potential biomarker for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. The protein is thought to be involved in the development and progression of these disorders by participating in the formation of the endosomal system and the delivery of harmful proteins to the brain.

In addition, POMGNT1 has also been shown to be involved in the development and progression of various cardiovascular diseases, including heart failure, hypertension, and myocardial infarction. This suggests that it may also be a potential biomarker for these conditions.

Conclusion

POMGNT1 is a transmembrane protein that is involved in the formation of the endosomal system and has been shown to play a role in the development and progression of various neurological and cardiovascular disorders. As a result, POMGNT1 is thought to be a potential drug target or biomarker for a variety of conditions. Further research is needed to fully understand the role of POMGNT1 in the development and progression of these disorders.

Protein Name: Protein O-linked Mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)

Functions: Participates in O-mannosyl glycosylation by catalyzing the addition of N-acetylglucosamine to O-linked mannose on glycoproteins (PubMed:11709191, PubMed:27493216, PubMed:28512129). Catalyzes the synthesis of the GlcNAc(beta1-2)Man(alpha1-)O-Ser/Thr moiety on alpha-dystroglycan and other O-mannosylated proteins, providing the necessary basis for the addition of further carbohydrate moieties (PubMed:11709191, PubMed:27493216). Is specific for alpha linked terminal mannose and does not have MGAT3, MGAT4, MGAT5, MGAT7 or MGAT8 activity

The "POMGNT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POMGNT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets